Meridian Bioscience Reports First Quarter Fiscal 2020 Operating Results and Reaffirms 2020 Guidance

Go back to Meridian Bioscience Reports First Quarter Fiscal 2020 Operating Results and Reaffirms 2020 Guidance
Meridian Bioscience, Inc. (NASDAQ: VIVO) Delayed: 5.60 -0.27 (4.6%)
Previous Close $5.87    52 Week High $21.49 
Open $5.52    52 Week Low $15.75 
Day High $6.04    P/E 6.36 
Day Low $5.50    EPS $0.88 
Volume 1,140,945